ResiQuant | $4,000,000 | (Mar 19, 2025)
Curevo Vaccine | $110,000,000 | (Mar 19, 2025)
Gradial | $13,000,000 | (Mar 19, 2025)
Certified by Founder
Lodge
StimOxyGen
start up
United Kingdom
- Coleraine, Derry
- 12/03/2025
- Unknown
- $1,939,450
StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia.
Hypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy.
We can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
- Industry Research Services
- Website https://stimoxygen.com/
- LinkedIn https://www.linkedin.com/company/stimoxygen/
Related People
Sian FarrellFounder
United Kingdom -
Londonderry, Northern Ireland
Co-founder and Chief Executive Officer at StimOxyGen.
Madison Scientific Inc | $7,000,000 | (Mar 19, 2025)
Equipt.ai | $3,200,000 | (Mar 19, 2025)
VIA(US) | $28,000,000 | (Mar 19, 2025)
brain.space | $11,000,000 | (Mar 19, 2025)
Mito Health (YC S24) | $2,200,000 | (Mar 19, 2025)
Arcade.dev | $12,000,000 | (Mar 19, 2025)
Orion Security | $6,000,000 | (Mar 19, 2025)
Rakurai | $3,000,000 | (Mar 18, 2025)
Darwin AI | $5,000,000 | (Mar 18, 2025)